Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315120 · ClinicalTrials.gov registry record · Phase 3
Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial
A Phase 3 study of Low Back Pain, sponsored by University of North Texas Health Science Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 455
- Enrollment target
- 1
- Study location
NCT00315120: Completed Phase 3 study of Low Back Pain, sponsored by University of North Texas Health Science Center.
NCT00315120 is a Phase 3 study of Low Back Pain that has completed, run by University of North Texas Health Science Center. The registered enrollment target is 455 participants, roughly in line with the 500-participant average among 122 other Low Back Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315120, a Phase 3 study of Low Back Pain, has completed, sponsored by University of North Texas Health Science Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 455 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether osteopathic manipulative treatment (a type of spinal manipulative therapy used by osteopathic physicians) and ultrasound physical therapy are effective in the treatment of chronic low back pain.
Primary Outcome
Comparison of the number (proportion) of participants in each study group who achieve a substantial improvement in low back pain over 12 weeks as determined by at least a 40-mm reduction (-40 mm) on the visual analogue scale score for pain compared with the baseline score. Changes in the visual analogue scale scores for pain over 12 weeks may potentially range from a 100-mm reduction (-100 mm) to a 100-mm increase (+100). Any reduction (negative score) represents an improvement in low back pain
Conditions Studied
Interventions
- PROCEDURE A. Active OMT and active UST
- PROCEDURE B. Sham OMT and active UST
- PROCEDURE C. Active OMT and sham UST
- PROCEDURE D. Sham OMT and sham UST
Study Locations (1)
Texas
- The Osteopathic Research Center - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 455 participants |
| Start Date | 2006-08 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
What the finished NCT00315120 record still lists
NCT00315120 is an interventional study that assigns participants to a tested intervention. The registered 455 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 500-participant average among 122 other Low Back Pain trials with a reported enrollment target.
The record links to 1 condition, with Low Back Pain appearing as the primary indexed condition, and to 4 interventions - of which A. Active OMT and active UST is the first listed.
NCT00315120 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00315120 about?
NCT00315120 is a clinical study titled "Osteopathic Health Outcomes in Chronic Low Back Pain (OSTEOPATHIC) Trial". The purpose of this study is to determine whether osteopathic manipulative treatment (a type of spinal manipulative therapy used by osteopathic physicians) and ultrasound physical therapy are effective in the treatment of chronic low back pain.
What is the current status of trial NCT00315120?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 455 participants. The study started on 2006-08. Estimated completion is 2011-01.
What conditions does trial NCT00315120 study?
This clinical trial studies the following conditions: Low Back Pain.
What interventions are being tested in trial NCT00315120?
The interventions under investigation include: A. Active OMT and active UST (PROCEDURE), B. Sham OMT and active UST (PROCEDURE), C. Active OMT and sham UST (PROCEDURE), D. Sham OMT and sham UST (PROCEDURE).
Who is sponsoring clinical trial NCT00315120?
This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00315120 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00315120's enrollment target sits among peer trials
455 13th of 122 higher than 109 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
RECRUITING · Phase 3
-
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
COMPLETED · Phase 3
-
Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
COMPLETED · Phase 3
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
COMPLETED · Phase 3
-
Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
COMPLETED · Phase 3
-
Acupuncture Analgesia in Relation to Psychiatric Comorbidity
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05541016 · 455 participants · Phase 2
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
- NCT06079346 · 455 participants · Phase 2
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer
- NCT06504446 · 455 participants · Phase 2
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
- NCT06725030 · 455 participants
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia